Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose.
Plasma glucose, immunoreactive insulin and C-peptide concentrations were compared in nine pancreas-kidney-transplanted patients (systemic venous drainage) and in ten non-diabetic kidney-transplanted patients with similar kidney function. In the basal state, C-peptide (insulin secretion) was similar, but immunoreactive insulin was higher and glucose concentrations were slightly, but significantly lower in pancrease-transplanted patients. After 50 g oral glucose, the plasma glucose and IR-insulin profiles were similar in both groups. The circumvention of first-pass hepatic insulin extraction (decreased endogenous insulin clearance) was compensated for by a significant reduction in insulin secretion (C-peptide; p = 0.036). In conclusion, hyperinsulinaemia in pancreas-transplanted patients with systemic venous drainage is significant only in the basal state. Insulin delivered into the portal and peripheral circulation, when leading to similar insulin profiles, maintains comparable degrees of glucose tolerance.
Nauck
M
M
Division of Gastroenterology and Endocrinology, Georg-August-University, Göttingen, FRG.
Büsing
M
M
Siegel
E G
EG
Talartschik
J
J
Baartz
A
A
Baartz
T
T
Hopt
U T
UT
Becker
H D
HD
Creutzfeldt
W
W
D001786:Blood Glucose / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D016030:Kidney Transplantation / Q000379:methods / Q000502:physiology*; D016035:Pancreas Transplantation / Q000379:methods* / Q000502:physiology*; D012016:Reference Values; D016042:Transplantation, Heterotopic; D014680:Veins / Q000601:surgery
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin